Pediatric gastroenterologists at Johns Hopkins Children's Center in Baltimore have launched a fecal transplant program after studies have shown it to be an effective treatment for drug-resistant C. difficile infections, according to a Science Daily report. The program will specifically help patients with recurrent diarrhea from the antibiotic-resistant pathogen. As many as 90 percent of adult patients treated with fecal transplants have been cured, and experts anticipate similar results in children.
Johns Hopkins Children's Center is one of few centers nationwide to offer the treatment. It can cause dehydration, anemia and pain.
More Articles on Gastroenterology:
New York Gastroenterology Associates Opens Scarsdale Office
Study: Propofol Sedation for Colonoscopy Not Worth High Cost
South Carolina Medical Endoscopy System Adopts New Colonoscopy Screening Tool